113 related articles for article (PubMed ID: 8220089)
1. Phenobarbital, drug metabolism, and human cancer.
Olsen JH; Wallin H; Boice JD; Rask K; Schulgen G; Fraumeni JF
Cancer Epidemiol Biomarkers Prev; 1993; 2(5):449-52. PubMed ID: 8220089
[TBL] [Abstract][Full Text] [Related]
2. Barbiturates, smoking, and bladder cancer risk.
Habel LA; Bull SA; Friedman GD
Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1049-50. PubMed ID: 9829715
[TBL] [Abstract][Full Text] [Related]
3. Altered aromatic amine metabolism in epileptic patients treated with phenobarbital.
Wallin H; Skipper PL; Tannenbaum SR; Jensen JP; Rylander L; Olsen JH
Cancer Epidemiol Biomarkers Prev; 1995; 4(7):771-3. PubMed ID: 8672995
[TBL] [Abstract][Full Text] [Related]
4. Antiepileptic treatment and risk for hepatobiliary cancer and malignant lymphoma.
Olsen JH; Schulgen G; Boice JD; Whysner J; Travis LB; Williams GM; Johnson FB; McGee JO
Cancer Res; 1995 Jan; 55(2):294-7. PubMed ID: 7812960
[TBL] [Abstract][Full Text] [Related]
5. Nonsmoking-related arylamine exposure and bladder cancer risk.
Skipper PL; Tannenbaum SR; Ross RK; Yu MC
Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):503-7. PubMed ID: 12814994
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers.
Salagovic J; Kalina I; Stubna J; Habalová V; Hrivnák M; Valanský L; Kohút A; Biros E
Neoplasma; 1998; 45(5):312-7. PubMed ID: 9921921
[TBL] [Abstract][Full Text] [Related]
7. Bulky DNA adducts and risk of cancer: a meta-analysis.
Veglia F; Matullo G; Vineis P
Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):157-60. PubMed ID: 12582026
[TBL] [Abstract][Full Text] [Related]
8. 4-Aminobiphenyl-hemoglobin adducts and risk of smoking-related disease in never smokers and former smokers in the European Prospective Investigation into Cancer and Nutrition prospective study.
Airoldi L; Vineis P; Colombi A; Olgiati L; Dell'Osta C; Fanelli R; Manzi L; Veglia F; Autrup H; Dunning A; Garte S; Hainaut P; Hoek G; Krzyzanowski M; Malaveille C; Matullo G; Overvad K; Tjonneland A; Clavel-Chapelon F; Linseisen J; Boeing H; Trichopoulou A; Palli D; Peluso M; Krogh V; Tumino R; Panico S; Bueno-De-Mesquita HB; Peeters PH; Lund E; Agudo A; Martinez C; Dorronsoro M; Barricarte A; Chirlaque MD; Quiros JR; Berglund G; Järvholm B; Hallmans G; Day NE; Allen N; Saracci R; Kaaks R; Riboli E
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2118-24. PubMed ID: 16172219
[TBL] [Abstract][Full Text] [Related]
9. A modified host cell reactivation assay to measure DNA repair capacity for removing 4-aminobiphenyl adducts: a pilot study of bladder cancer.
Lin J; Kadlubar FF; Spitz MR; Zhao H; Wu X
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1832-6. PubMed ID: 16030125
[TBL] [Abstract][Full Text] [Related]
10. Measurement of 4-aminobiphenyl-hemoglobin adducts in lung cancer cases and controls.
Weston A; Caporaso NE; Taghizadeh K; Hoover RN; Tannenbaum SR; Skipper PL; Resau JH; Trump BF; Harris CC
Cancer Res; 1991 Oct; 51(19):5219-23. PubMed ID: 1913645
[TBL] [Abstract][Full Text] [Related]
11. A prospective cohort study of bladder cancer risk in relation to active cigarette smoking and household exposure to secondhand cigarette smoke.
Alberg AJ; Kouzis A; Genkinger JM; Gallicchio L; Burke AE; Hoffman SC; Diener-West M; Helzlsouer KJ; Comstock GW
Am J Epidemiol; 2007 Mar; 165(6):660-6. PubMed ID: 17204516
[TBL] [Abstract][Full Text] [Related]
12. Environmental tobacco smoke and bladder cancer risk in never smokers of Los Angeles County.
Jiang X; Yuan JM; Skipper PL; Tannenbaum SR; Yu MC
Cancer Res; 2007 Aug; 67(15):7540-5. PubMed ID: 17671226
[TBL] [Abstract][Full Text] [Related]
13. A nested case-control study on alcohol drinking, tobacco smoking, and cancer.
Murata M; Takayama K; Choi BC; Pak AW
Cancer Detect Prev; 1996; 20(6):557-65. PubMed ID: 8939341
[TBL] [Abstract][Full Text] [Related]
14. Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction.
Marcus PM; Hayes RB; Vineis P; Garcia-Closas M; Caporaso NE; Autrup H; Branch RA; Brockmöller J; Ishizaki T; Karakaya AE; Ladero JM; Mommsen S; Okkels H; Romkes M; Roots I; Rothman N
Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):461-7. PubMed ID: 10815690
[TBL] [Abstract][Full Text] [Related]
15. Chronic, topical administration of 4-aminobiphenyl induces tissue-specific DNA adducts in mice.
Underwood PM; Zhou Q; Jaeger M; Reilman R; Pinney S; Warshawsky D; Talaska G
Toxicol Appl Pharmacol; 1997 Jun; 144(2):325-31. PubMed ID: 9194416
[TBL] [Abstract][Full Text] [Related]
16. DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk.
Stern MC; Umbach DM; van Gils CH; Lunn RM; Taylor JA
Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):125-31. PubMed ID: 11219769
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P-450 and acetyltransferase expression as biomarkers of carcinogen-DNA adduct levels and human cancer susceptibility.
Badawi AF; Stern SJ; Lang NP; Kadlubar FF
Prog Clin Biol Res; 1996; 395():109-40. PubMed ID: 8895986
[TBL] [Abstract][Full Text] [Related]
18. Molecular epidemiology of bladder cancer.
Vineis P; Martone T
Ann Ist Super Sanita; 1996; 32(1):21-7. PubMed ID: 8967722
[TBL] [Abstract][Full Text] [Related]
19. Risk for smoking-related cancer among relatives of lung cancer patients.
Etzel CJ; Amos CI; Spitz MR
Cancer Res; 2003 Dec; 63(23):8531-5. PubMed ID: 14679021
[TBL] [Abstract][Full Text] [Related]
20. Effect of vitamin intervention on the relationship between GSTM1, smoking, and lung cancer risk among male smokers.
Woodson K; Stewart C; Barrett M; Bhat NK; Virtamo J; Taylor PR; Albanes D
Cancer Epidemiol Biomarkers Prev; 1999 Nov; 8(11):965-70. PubMed ID: 10566550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
